Prevalence of target organ damage and metabolic abnormalities in resistant hypertension

Medicine and Dentistry

• Albumin 16%
• Anthropometry 16%
• Antihypertensive Agent 33%
• Blood Pressure Monitoring 16%
• Cardiovascular Risk 16%
• Cohort Effect 16%
• Combination Therapy 16%
• Creatinine 16%
• Diagnosis 16%
• Diastolic Blood Pressure 16%
• Diuretic Agent 16%
• Echocardiography 16%
• Female 33%
• Hypertension 50%
• Left Atrial Enlargement 33%
• Left Atrium 16%
• Left Ventricular Hypertrophy 33%
• Male 33%
• Metabolic Syndrome 66%
• Microalbuminuria 33%
• Obesity 50%
• Patient 100%
• Prevalence 83%
• Resistant Hypertension 83%
• Systolic Blood Pressure 16%
• Target Organ 50%
• Urinary System 16%
• Woman 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Albumin 16%
• Antihypertensive Agent 33%
• Cardiovascular Risk 16%
• Creatinine 16%
• Diabetes Mellitus 33%
• Diuretic Agent 16%
• Epidemiology 16%
• Heart Left Ventricle Hypertrophy 33%
• Hypertension 50%
• Metabolic Syndrome X 66%
• Microalbuminuria 33%
• Obesity 50%
• Prevalence 83%
• Resistant Hypertension 83%